インスリン送達装置市場は、予測期間中に8.5%のCAGRで成長し、2023年の308億ドルから2028年までに462億ドルに達すると予想されます。世界のインスリン送達装置市場で活動している著名なプレーヤーは、Embecta Corp. (旧 Becton, Dickinson and Company Diabetes Care Business (米国)、Ypsomed Holding AG (スイス)、Tandem Diabetes Care (米国)、Insulet Corporation (米国)、Biocon です。 Limited (インド)、Novo Nordisk A/S (デンマーク)、Medtronic (アイルランド)、Sanofi (フランス)、Eli Lilly and Company (米国)、Roche Diabetes Care (スイス)、Owen Mumford (英国)、Mrdtrum Technologies Inc.、テルモ株式会社（日本）、Wockhardt（インド）、Cerur Corporation（スイス）、EoFlow CO., Ltd.（韓国）、Hindustan Syringes & Medical Devices Ltd（インド）、Sooil Developments CO., Ltd（韓国）、Sungshim Medical Co., Ltd. (韓国), Vicentra B.V. (オランダ), Debiotech SA (スイス), Jiangsu Delfu Medical Device Co., Ltd (中国), Haselmeier (ドイツ), Mannkind Corporation (米国), HTL-Sterfa S.A. (ポーランド)
目次
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 20)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 25)
2.1 RESEARCH DATA
FIGURE 1 INSULIN DELIVERY DEVICES MARKET: RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2022)
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY-WISE REVENUE SHARE ANALYSIS (2022)
FIGURE 7 INSULIN DELIVERY DEVICES INDUSTRY: CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF MARKET
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ESTIMATION
2.5 STUDY ASSUMPTIONS
2.6 IMPACT OF RECESSION
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS. 2021-2027 (%GROWTH)
3 EXECUTIVE SUMMARY (Page No. - 38)
FIGURE 10 INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 11 INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF MARKET
4 PREMIUM INSIGHTS (Page No. - 41)
4.1 INSULIN DELIVERY DEVICES: MARKET OVERVIEW
FIGURE 13 INCREASING TECHNOLOGICAL ADVANCEMENTS IN INSULIN DELIVERY DEVICES TO DRIVE MARKET
4.2 ASIA PACIFIC: MARKET, BY TYPE AND COUNTRY (2022)
FIGURE 14 INSULIN PENS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
4.3 INSULIN DELIVERY DEVICES INDUSTRY: GEOGRAPHICAL MIX
FIGURE 15 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
4.4 MARKET: REGIONAL MIX (2023-2028)
FIGURE 16 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD (2023-2028)
4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS
FIGURE 17 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 45)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 18 INSULIN DELIVERY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Growing prevalence of diabetic population
FIGURE 19 GLOBAL PREVALENCE OF DIABETES IN INDIVIDUALS AGED 20-79 YEARS, 2015-2021 (MILLIONS)
FIGURE 20 PROJECTION OF DIABETES FOR INDIVIDUALS AGED 20-79 YEARS, 2030-2045 (MILLIONS)
FIGURE 21 TOP TEN COUNTRIES WITH HIGHEST COUNT OF DIABETICS (20-79 YEARS), 2021 & 2045
5.2.1.2 Technological advancements in insulin delivery devices
FIGURE 22 ADVANCEMENTS IN INSULIN DELIVERY DEVICES
5.2.1.3 Government support and favorable reimbursement schemes to favor market growth
5.2.2 RESTRAINTS
5.2.2.1 High costs and lack of reimbursement in developing countries
5.2.2.2 Needle anxiety in patients to affect growth of pen needles and syringes market
5.2.2.3 Oral insulin as alternative drug delivery method
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing R&D activities and strategic partnerships
5.2.3.2 Increasing healthcare expenditure on diabetes care
FIGURE 23 TOTAL HEALTH EXPENDITURE ON DIABETES CARE, 2021-2045 (USD BILLION)
5.2.3.3 Advances in syringe and needle technology
5.2.3.4 Mandates pertaining to safety-engineered medical needles to encourage market growth
5.2.4 CHALLENGES
5.2.4.1 Needlestick injuries and misuse of injection pens
5.2.4.2 Lack of interoperability among insulin delivery devices
5.3 PORTER’S FIVE FORCES ANALYSIS
TABLE 2 INSULIN DELIVERY DEVICES INDUSTRY: PORTER’S FIVE FORCES ANALYSIS
5.3.1 INTENSITY OF COMPETITIVE RIVALRY
5.3.2 BARGAINING POWER OF SUPPLIERS
5.3.3 BARGAINING POWER OF BUYERS
5.3.4 THREAT OF SUBSTITUTES
5.3.5 THREAT OF NEW ENTRANTS
5.4 REGULATORY ANALYSIS
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 4 US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
FIGURE 24 FDA 510(K) APPROVAL PROCESS
5.4.1.2 Canada
5.4.2 EUROPE
FIGURE 25 CE MARK APPROVAL PROCESS FOR INSULIN DELIVERY DEVICES
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 5 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODY
5.4.3.2 China
TABLE 6 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
5.4.3.3 India
TABLE 7 INDIA: MEDICAL DEVICE CLASSIFICATION
5.4.3.4 Australia
FIGURE 26 SUMMARY OF APPROVAL, ACCESS, AND DISTRIBUTION PATHWAYS FOR NEW TECHNOLOGY USED FOR INSULIN DRUG DELIVERY DEVICES
5.4.4 REST OF THE WORLD
5.5 INDUSTRY INSIGHTS
5.5.1 GROWING DEMAND FOR HYBRID CLOSED-LOOP SYSTEMS/ARTIFICIAL PANCREAS DEVICE SYSTEMS
TABLE 8 HYBRID CLOSED-LOOP SYSTEMS: CURRENT MARKET SCENARIO
5.5.2 SYNCHRONIZATION OF SMART INSULIN PENS WITH CGM SYSTEMS TO PROMOTE DIABETES DATA SHARING
TABLE 9 MAJOR SMART INSULIN PENS AVAILABLE GLOBALLY
5.5.3 INCREASING NUMBER OF COLLABORATIONS AMONG STAKEHOLDERS
TABLE 10 INSULIN DELIVERY DEVICE MARKET: RECENT COLLABORATIONS
5.6 REIMBURSEMENT SCENARIO
TABLE 11 INSULIN DELIVERY DEVICES: GLOBAL COVERAGE AND REIMBURSEMENT
5.6.1 US
5.6.2 CANADA
5.6.3 UK
5.6.4 AUSTRALIA
5.6.5 OTHER COUNTRIES
5.7 TECHNOLOGICAL ANALYSIS
5.8 KEY CONFERENCES & EVENTS, 2023-2024
TABLE 12 MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.9 PRICING ANALYSIS
5.9.1 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT
TABLE 13 AVERAGE SELLING PRICE OF INSULIN PENS, BY KEY PLAYER
TABLE 14 AVERAGE SELLING PRICE OF INSULIN PUMPS, BY KEY PLAYER
5.10 PATENT ANALYSIS
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2011-MAY 2023)
5.10.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTES) FOR INSULIN DELIVERY DEVICES PATENTS (JANUARY 2011-MAY 2023)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR INSULIN DELIVERY DEVICES (JANUARY 2011-MAY 2023)
5.11 VALUE CHAIN ANALYSIS
FIGURE 30 MARKET: VALUE CHAIN ANALYSIS
5.12 ECOSYSTEM MARKET MAP
FIGURE 31 INSULIN DELIVERY DEVICE MARKET: ECOSYSTEM MAPPING
5.13 USE CASES
TABLE 15 T:SLIM X2 INSULIN PUMPS TO OFFER CONTINUED IMPROVEMENTS IN FUNCTIONALITY, SAFETY, AND WEARABILITY OF PUMPS
TABLE 16 AUTOMATED AND SMART INSULIN DELIVERY DEVICE FOR DIABETES CARE
TABLE 17 CONTRIBUTION OF SMART INSULIN PEN IN LIGHTENING DIABETES MANAGEMENT LOAD
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INSULIN DELIVERY DEVICES
5.14.2 BUYING CRITERIA FOR INSULIN DELIVERY DEVICES
FIGURE 33 KEY BUYING CRITERIA FOR END USERS
6 INSULIN DELIVERY DEVICES MARKET, BY TYPE (Page No. - 80)
6.1 INTRODUCTION
TABLE 18 INSULIN DELIVERY DEVICES INDUSTRY, BY TYPE, 2021-2028 (USD MILLION)
TABLE 19 MARKET, BY TYPE, 2021-2028 (THOUSAND UNITS)
6.2 INSULIN PENS
6.2.1 ADVANCED AND CONVENIENT SOLUTIONS FOR INSULIN ADMINISTRATION TO DRIVE MARKET
TABLE 20 INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 21 INSULIN PENS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 INSULIN PENS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
6.2.2 REUSABLE INSULIN PENS
6.2.2.1 Technology innovations to boost growth
TABLE 23 REUSABLE INSULIN PENS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.2.3 DISPOSABLE INSULIN PENS
6.2.3.1 Shift toward eco-friendly environment to restrain growth of market during forecast period
TABLE 24 DISPOSABLE INSULIN PENS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3 INSULIN PUMPS
6.3.1 NEWER AND MORE REFINED TECHNOLOGY TO DRIVE INSULIN PUMPS MARKET
TABLE 25 INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 26 INSULIN PUMPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 27 INSULIN PUMPS MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
6.3.2 TETHERED INSULIN PUMPS
6.3.2.1 Increasing collaborations and partnerships between companies to develop integrated CGM systems to drive market
TABLE 28 TETHERED INSULIN PUMPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.3.3 TUBELESS INSULIN PUMPS
6.3.3.1 Use of artificial intelligence and technological advancements to boost market
TABLE 29 TUBELESS INSULIN PUMPS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.4 INSULIN PEN NEEDLES
TABLE 30 INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 31 INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 32 INSULIN PEN NEEDLES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
6.4.1 STANDARD INSULIN PEN NEEDLES
6.4.1.1 Affordability of standard insulin pen needles over safety pen needles to propel growth
TABLE 33 STANDARD INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 34 STANDARD INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.4.2 SAFETY INSULIN PEN NEEDLES
6.4.2.1 Reducing chances of infection and accidental pricking to drive market
TABLE 35 SAFETY INSULIN PEN NEEDLES OFFERED BY KEY PLAYERS
TABLE 36 SAFETY INSULIN PEN NEEDLES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
6.5 INSULIN SYRINGES
6.5.1 SAFETY CONCERNS AND INCREASING AWARENESS OF AFFORDABLE ALTERNATIVES TO RESTRAIN GROWTH
TABLE 37 INSULIN SYRINGES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 38 INSULIN SYRINGES MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
6.6 OTHER INSULIN DELIVERY DEVICES
TABLE 39 OTHER MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 40 OTHER MARKET, BY REGION, 2021-2028 (THOUSAND UNITS)
7 INSULIN DELIVERY DEVICES MARKET, BY END USER (Page No. - 100)
7.1 INTRODUCTION
TABLE 41 INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
7.2 PATIENTS/HOME CARE
7.2.1 INCREASING AFFORDABILITY OF SELF-MONITORING SYSTEMS AND INSULIN DELIVERY DEVICES TO FUEL GROWTH
TABLE 42 MARKET FOR PATIENTS/HOME CARE, BY COUNTRY, 2021-2028 (USD MILLION)
7.3 HOSPITALS & CLINICS
7.3.1 RISING DEMAND FOR POINT-OF-CARE TESTING IN HOSPITALS TO BOOST MARKET
TABLE 43 MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021-2028 (USD MILLION)
8 INSULIN DELIVERY DEVICES MARKET, BY REGION (Page No. - 104)
8.1 INTRODUCTION
FIGURE34 INSULIN DELIVERY DEVICES INDUSTRY: GEOGRAPHIC SNAPSHOT
TABLE 44 MARKET, BY REGION, 2021-2028 (USD MILLION)
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA: RECESSION IMPACT
FIGURE35 NORTH AMERICA: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 46 NORTH AMERICA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 47 NORTH AMERICA: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 48 NORTH AMERICA: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 49 NORTH AMERICA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 50 NORTH AMERICA: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.2.2 US
8.2.2.1 Rising prevalence of diabetes and favorable reimbursement scenario to drive market
8.2.2.2 Growing venture capital investments and issuance of IPOs to propel market growth
TABLE 51 US: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 52 US: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 53 US: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 54 US: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 55 US: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.2.3 CANADA
8.2.3.1 High prevalence of diabetes and favorable reimbursement for insulin delivery devices to boost market
TABLE 56 CANADA: ELIGIBILITY FOR INSULIN PUMPS AND SUPPLIES FOR TYPE I DIABETES, APRIL 2021
8.2.3.2 Regulations for usage of safety-engineered needles to drive market
TABLE 57 CANADA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 58 CANADA: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 59 CANADA: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 60 CANADA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 61 CANADA: INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.3 EUROPE
8.3.1 EUROPE: RECESSION IMPACT
8.3.1.1 EU’s directive on prevention of sharps injuries in hospitals and healthcare sector to drive market
TABLE 62 EUROPE: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 63 EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 64 EUROPE: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 65 EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 66 EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 67 EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.3.2 GERMANY
8.3.2.1 High prevalence of diabetes and favorable reimbursement for insulin devices to propel market
TABLE 68 GERMANY: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 69 GERMANY: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 70 GERMANY: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 71 GERMANY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 72 GERMANY: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.3.3 UK
8.3.3.1 Role of Diabetes UK in research and diabetes care to boost market
8.3.3.2 Insulin pump penetration to boost market
TABLE 73 UK: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 74 UK: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 75 UK: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 76 UK: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 77 UK: INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.3.4 FRANCE
8.3.4.1 High insurance coverage and increasing affordability to drive market
TABLE 78 FRANCE: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 79 FRANCE: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 80 FRANCE: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 81 FRANCE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 82 FRANCE: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.3.5 ITALY
8.3.5.1 Regional variations in terms of coverage and benefits to hinder market growth
TABLE 83 ITALY: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 84 ITALY: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 85 ITALY: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 86 ITALY: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 87 ITALY: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.3.6 SPAIN
8.3.6.1 Regulations for mandatory use of safety needles and increase in diabetic population to propel market
TABLE 88 SPAIN: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 89 SPAIN: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 90 SPAIN: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 91 SPAIN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 92 SPAIN: INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.3.7 REST OF EUROPE
8.3.7.1 Strong presence of major insulin delivery device manufacturers to drive market
TABLE 93 INDICATIVE LIST OF COMPANIES HEADQUARTERED IN REST OF EUROPE
FIGURE 36 TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS) IN MILLIONS
TABLE 94 REST OF EUROPE: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 REST OF EUROPE: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 96 REST OF EUROPE: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 97 REST OF EUROPE: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 98 REST OF EUROPE: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC: RECESSION IMPACT
FIGURE 37 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET SNAPSHOT
8.4.1.1 High diabetes incidence and population in Asia Pacific to boost market
TABLE 99 ASIA PACIFIC: DIABETES PREVALENCE, BY COUNTRY
8.4.1.2 Partnerships among global and local players in Asia Pacific to drive market
TABLE 100 ASIA PACIFIC: MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 101 ASIA PACIFIC: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 102 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 103 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 105 ASIA PACIFIC: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.4.2 JAPAN
8.4.2.1 High adoption of insulin pens and approval of injectable insulin to propel growth
TABLE 106 JAPAN: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 107 JAPAN: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 108 JAPAN: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 109 JAPAN: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 110 JAPAN: INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.4.3 CHINA
8.4.3.1 Sharp increase in diabetes in past decade and government support to drive market
TABLE 111 CHINA: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 112 CHINA: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 113 CHINA: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 114 CHINA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 115 CHINA: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.4.4 INDIA
8.4.4.1 Government initiatives to promote domestic manufacture of medical devices to drive market
TABLE 116 INDIA: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 117 INDIA: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 118 INDIA: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 119 INDIA: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 120 INDIA: MARKET, BY END USER, 2021-2028 (USD MILLION)
8.4.5 REST OF ASIA PACIFIC
8.4.5.1 Vietnam: Large diabetic population to boost market
8.4.5.2 Australia: Government initiatives to broaden patient access to diabetes products
TABLE 121 ASIA PACIFIC: INSULIN DELIVERY DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 122 ASIA PACIFIC: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 123 ASIA PACIFIC: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 124 ASIA PACIFIC: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 125 ASIA PACIFIC: INSULIN DELIVERY DEVICES INDUSTRY, BY END USER, 2021-2028 (USD MILLION)
8.5 REST OF THE WORLD
8.5.1 REST OF THE WORLD: RECESSION IMPACT
8.5.1.1 Increasing diabetic population to propel market
FIGURE 38 AFRICA: TOP FIVE COUNTRIES WITH HIGHEST NUMBER OF DIABETICS (20-79 YEARS)
8.5.1.2 Favorable government policies and increasing prevalence of diabetic population to drive market
FIGURE 39 COUNT OF DIABETICS (20-79 YEARS) IN LATIN AMERICA REGION: TOP FIVE COUNTRIES
TABLE 126 REST OF THE WORLD: MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 127 REST OF THE WORLD: INSULIN PENS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 128 REST OF THE WORLD: INSULIN PUMPS MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 129 REST OF THE WORLD: INSULIN PEN NEEDLES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 130 REST OF THE WORLD: MARKET, BY END USER, 2021-2028 (USD MILLION)
9 COMPETITIVE LANDSCAPE (Page No. - 155)
9.1 OVERVIEW
9.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS
TABLE 131 INSULIN DELIVERY DEVICES MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
9.3 MARKET SHARE ANALYSIS
FIGURE40 MARKET SHARE ANALYSIS FOR INSULIN PENS, BY KEY PLAYERS, 2022
FIGURE41 MARKET SHARE ANALYSIS FOR INSULIN PUMPS, BY KEY PLAYERS, 2022
FIGURE42 MARKET SHARE ANALYSIS FOR INSULIN PEN NEEDLES, BY KEY PLAYERS, 2022
FIGURE43 MARKET SHARE ANALYSIS FOR INSULIN SYRINGES, BY KEY PLAYERS, 2022
9.4 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE44 REVENUE ANALYSIS OF KEY PLAYERS (2020-2022)
9.5 MARKET RANKING ANALYSIS
FIGURE45 INSULIN DELIVERY DEVICES INDUSTRY RANKING, BY KEY PLAYERS, 2022
9.6 COMPANY EVALUATION QUADRANT: KEY PLAYERS
9.6.1 STARS
9.6.2 EMERGING LEADERS
9.6.3 PERVASIVE PLAYERS
9.6.4 PARTICIPANTS
FIGURE46 MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
9.7 COMPANY EVALUATION QUADRANT: START-UPS & SMES
9.7.1 PROGRESSIVE COMPANIES
9.7.2 DYNAMIC COMPANIES
9.7.3 STARTING BLOCKS
9.7.4 RESPONSIVE COMPANIES
FIGURE47 MARKET: COMPANY EVALUATION MATRIX FOR START-UPS (2022)
9.8 COMPANY FOOTPRINT OF PLAYERS IN INSULIN DELIVERY DEVICES INDUSTRY
TABLE 132 MARKET: COMPANY FOOTPRINT (2022)
9.8.1 TYPE FOOTPRINT
TABLE 133 MARKET: TYPE FOOTPRINT (2022)
9.8.2 REGIONAL FOOTPRINT
TABLE 134 MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS (2022)
9.9 COMPETITIVE SCENARIO
9.9.1 PRODUCT LAUNCHES
TABLE 135 PRODUCT LAUNCHES, JANUARY 2019-JUNE 2023
9.9.2 DEALS
TABLE 136 DEALS, JANUARY 2019-JUNE 2023
9.9.3 OTHER DEVELOPMENTS
TABLE 137 OTHER DEVELOPMENTS, JANUARY 2019-JUNE 2023
10 COMPANY PROFILES (Page No. - 171)
10.1 KEY PLAYERS
(Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View)*
10.1.1 EMBECTA CORP. (FORMERLY BECTON, DICKINSON AND COMPANY DIABETES CARE BUSINESS)
TABLE 138 EMBECTA CORP.: COMPANY OVERVIEW
FIGURE 48 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
10.1.2 NOVO NORDISK A/S
TABLE 139 NOVO NORDISK A/S: COMPANY OVERVIEW
FIGURE 49 NOVO NORDISK A/S: COMPANY SNAPSHOT (2022)
10.1.3 MEDTRONIC PLC
TABLE 140 MEDTRONIC PLC: COMPANY OVERVIEW
FIGURE 50 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
10.1.4 SANOFI
TABLE 141 SANOFI: COMPANY OVERVIEW
FIGURE 51 SANOFI: COMPANY SNAPSHOT (2022)
10.1.5 LILLY
TABLE 142 LILLY: COMPANY OVERVIEW
FIGURE 52 LILLY: COMPANY SNAPSHOT (2022)
10.1.6 YPSOMED HOLDING AG
TABLE 143 YPSOMED HOLDING AG: COMPANY OVERVIEW
FIGURE 53 YPSOMED HOLDING AG: COMPANY SNAPSHOT (2023)
10.1.7 TANDEM DIABETES CARE, INC.
TABLE 144 TANDEM DIABETES CARE, INC.: COMPANY OVERVIEW
FIGURE 54 TANDEM DIABETES CARE, INC.: COMPANY SNAPSHOT (2022)
10.1.8 INSULET CORPORATION
TABLE 145 INSULET CORPORATION: COMPANY OVERVIEW
FIGURE 55 INSULET CORPORATION: COMPANY SNAPSHOT (2022)
10.1.9 BIOCON LIMITED
TABLE 146 BIOCON LIMITED: COMPANY OVERVIEW
FIGURE 56 BIOCON LIMITED: COMPANY SNAPSHOT (2022)
10.1.10 ROCHE DIABETES CARE
TABLE 147 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
FIGURE 57 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
10.1.11 OWEN MUMFORD
TABLE 148 OWEN MUMFORD: COMPANY OVERVIEW
10.1.12 MEDTRUM TECHNOLOGIES INC.
TABLE 149 MEDTRUM TECHNOLOGIES INC.: COMPANY OVERVIEW
10.1.13 TERUMO CORPORATION
TABLE 150 TERUMO CORPORATION: COMPANY OVERVIEW
FIGURE 58 TERUMO CORPORATION: COMPANY SNAPSHOT (2021)
10.1.14 WOCKHARDT
TABLE 151 WOCKHARDT: COMPANY OVERVIEW
FIGURE 59 WOCKHARDT: COMPANY SNAPSHOT (2021)
*Details on Business Overview, Products/Solutions/Services offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
10.2 OTHER PLAYERS
10.2.1 CEQUR CORPORATION
10.2.2 EOFLOW CO., LTD.
10.2.3 HINDUSTAN SYRINGES & MEDICAL DEVICES LTD
10.2.4 SOOIL DEVELOPMENTS CO., LTD
10.2.5 SUNGSHIM MEDICAL CO., LTD.
10.2.6 VICENTRA B.V.
10.2.7 DEBIOTECH SA
10.2.8 JIANGSU DELFU MEDICAL DEVICE CO., LTD
10.2.9 HASELMEIER
10.2.10 MANNKIND CORPORATION
10.2.11 HTL-STREFA S.A.
11 APPENDIX (Page No. - 220)
11.1 DISCUSSION GUIDE
11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
11.3 CUSTOMIZATION OPTIONS
11.4 RELATED REPORTS
11.5 AUTHOR DETAILS
